BridgeBio Pharma | 8-K: BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update
May 2 07:33 ET
BridgeBio Pharma | DEFA14A: Others
Apr 25 22:17 ET
BridgeBio Pharma | DEF 14A: Definitive information statements
Apr 25 16:07 ET
BridgeBio Pharma | 8-K: Current report
Mar 6 17:16 ET
BridgeBio Pharma | 8-K: Current report
Mar 4 07:05 ET
BridgeBio Pharma | 8-K: BridgeBio Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
Feb 22 07:36 ET
BridgeBio Pharma | 8-K: Current report
Jan 18 00:00 ET
BridgeBio Pharma | 8-K: Current report
Jan 8 00:00 ET
BridgeBio Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Jan 5 00:00 ET
BridgeBio Pharma | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Nov 2, 2023 16:59 ET
BridgeBio Pharma | 8-K: BridgeBio Pharma Reports Third Quarter 2023 Financial Results and Business Update
Nov 2, 2023 07:31 ET
BridgeBio Pharma | 8-K: Current report
Sep 25, 2023 16:00 ET
BridgeBio Pharma | 8-K: BridgeBio Pharma Reports Second Quarter 2023 Financial Results and Business Update
Aug 3, 2023 07:32 ET
BridgeBio Pharma | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
Jul 26, 2023 16:06 ET
BridgeBio Pharma | 8-K: Current report
Jul 17, 2023 07:23 ET
BridgeBio Pharma | 8-K: Current report
Jun 22, 2023 16:05 ET
BridgeBio Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
May 4, 2023 17:20 ET
BridgeBio Pharma | 8-K: Current report
May 4, 2023 17:18 ET
BridgeBio Pharma | S-3ASR: Automatic shelf registration statement of securities of well-known seasoned issuers
May 4, 2023 16:55 ET
BridgeBio Pharma | 8-K: BridgeBio Pharma Reports First Quarter 2023 Financial Results and Business Update
May 4, 2023 07:46 ET
No Data
No Data